查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942531

2026年全球心血管植入市场报告

Cardiovascular Implants Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心血管植入市场成长显着，预计将从2025年的286.8亿美元成长到2026年的305.2亿美元，复合年增长率为6.4%。过去几年的成长可归因于多种因素，例如心血管疾病盛行率的上升、介入性心臟病手术的增加、医院心臟护理部门的扩张、植入式心臟起搏器的日益普及以及先进生物材料的广泛应用。

预计未来几年心血管植入市场将稳定成长，到2030年市场规模将达390.9亿美元，复合年增长率（CAGR）为6.4%。预测期内的成长要素包括人口老化、对微创心臟手术需求的成长、结构性心臟疾病治疗方法的不断丰富、对个人化心血管护理的日益重视，以及植入材料和设计方面的技术创新。预测期内的主要趋势包括微创心血管植入的日益普及、药物释放型支架和生物可吸收支架的广泛应用、经导管心臟瓣膜置换术的日益受到青睐、先进心臟节律管理装置的日益普及，以及对植入物长期耐久性的日益关注。

预计未来几年，心臟病盛行率的不断上升将推动心血管植入市场的成长。心臟病是指影响心臟和血管的各种疾病，例如冠状动脉疾病、心臟衰竭、心律不整和瓣膜疾病。冠状动脉疾病和心臟衰竭等心臟病的增加，推动了包括支架和起搏器在内的心血管植入的需求成长。这些植入能够支持心臟功能和血液循环，调节心率，并监测心臟衰竭患者的心臟活动。例如，英国心臟基金会（BHF）是一家致力于资助心臟和循环系统疾病研究并提高公众意识的英国慈善机构，该机构于2024年9月报告称，英国约有760万人患有心臟和循环系统疾病。预计到2030年，这数字将增加100万，到2040年将再增加200万。因此，心臟病患病率的上升趋势正在推动心血管植入市场的扩张。

心血管植入市场的主要企业正致力于整合包括人工智慧 (AI) 在内的先进技术，以最大限度地提高市场利润并改善患者照护和治疗。心臟监测技术的进步包括持续追踪和记录患者的心率活动，用于诊断和管理心臟疾病。 2023 年 6 月，百多力 (BIOTRONIK SE & Co. KG) 推出了 BIOMONITOR IV，这是全球首款将智慧心电图 (SmartECG) 技术与人工智慧相结合的植入式心臟监测器 (ICM)。这项创新技术可将假阳性检测率降低 86%，同时维持 98% 的实际癫痫发作检测准确率。 BIOMONITOR IV 还具有其他优势，例如更长的电池续航时间和无线连接功能，可实现无缝资料传输和远端监测，从而减少患者频繁就医的需求。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球心血管植入市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 微创心血管植入的应用日益普及
    • 药物释放型和生物可吸收支架的使用日益增多
    • 增加经导管心臟瓣膜置换术的选择
    • 扩展先进心臟节律管理设备
    • 越来越重视植入的长期耐久性

第五章 终端用户产业市场分析

  • 医院
  • 心臟中心
  • 门诊手术中心
  • 专科心臟诊所
  • 介入性心臟病中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球心血管植入市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球心血管植入市场规模、对比及成长率分析
  • 全球心血管植入市场表现：规模与成长，2020-2025年
  • 全球心血管植入市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 冠状动脉支架、植入式心臟整流去颤器（ICD）、心臟瓣膜、植入式心臟节律器、心臟再同步治疗（CRT）装置、週边支架
  • 材料
  • 金属及合金、聚合物、生物材料
  • 透过使用
  • 心律不整、急性心肌梗塞、心肌缺血等适应症
  • 最终用户
  • 医院、门诊手术中心及心臟中心
  • 按类型细分：冠状动脉支架
  • 药物释放型支架、裸金属支架、生物可吸收支架
  • 依类型细分：植入式心臟整流去颤器（ICD）
  • 单腔ICD、双腔ICD、双心室ICD
  • 按类型细分：心臟瓣膜
  • 人工心臟瓣膜、生物人工心臟瓣膜、经​​导管心臟瓣膜
  • 按类型细分：植入式心臟节律器
  • 单腔心律调节器、双腔心律调节器、双心室节律器
  • 依类型细分：心臟再同步治疗（CRT）设备
  • CRT-P装置（心臟节律器）、CRT-D装置（去心房颤动）
  • 按类型细分：週边支架
  • 颈动脉支架、肾动脉支架、股动脉支架

第十章 区域与国家分析

  • 全球心血管植入市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球心血管植入市场：依国家划分、绩效及预测（2020-2025年、2025-2030年预测、2035年预测）

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 心血管植入市场：竞争格局与市场占有率（2024 年）
  • 心血管植入市场：公司估值矩阵
  • 心血管植入市场：公司概况
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • B. Braun Melsungen AG
    • Edwards Lifesciences Corporation

第37章：其他领先和创新企业

  • WL Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年心血管植入市场：提供新机会的国家
  • 2030年心血管植入市场：充满新机会的细分市场
  • 2030年心血管植入市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MCIMP04_G26Q1

Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.

The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.

Tariffs are influencing the cardiovascular implants market by increasing costs of imported metals, polymers, electronic components, and precision manufacturing equipment used in stents, pacemakers, valves, and defibrillators. Hospitals and cardiac centers in North America and Europe are most affected due to dependence on imported implant components, while Asia-Pacific faces cost pressure on export manufacturing. These tariffs are elevating device prices and affecting procurement budgets. At the same time, they are supporting localized manufacturing, regional supply chain development, and innovation in cost-optimized cardiovascular implant technologies.

The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular implants market size has grown strongly in recent years. It will grow from $28.68 billion in 2025 to $30.52 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising interventional cardiology procedures, expansion of hospital cardiac care units, growing adoption of implantable pacemakers, availability of advanced biomaterials.

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $39.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive cardiac treatments, expansion of structural heart disease therapies, growing focus on personalized cardiovascular care, increasing innovation in implant materials and designs. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular implants, rising use of drug-eluting and bioabsorbable stents, growing preference for transcatheter heart valve procedures, expansion of advanced cardiac rhythm management devices, enhanced focus on long-term implant durability.

The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.

Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.

In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.

Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd

North America was the largest region in the cardiovascular implants market in 2025. The regions covered in the cardiovascular implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular Implants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
  • 2) By Material: Metals and Alloys; Polymers; Biological Materials
  • 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
  • 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Coronary Stent: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents
  • 2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD; Dual-Chamber ICD; Biventricular ICD
  • 3) By Heart Valve: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves
  • 4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular Pacemaker
  • 5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers); CRT-D Devices (Defibrillators)
  • 6) By Peripheral Stent: Carotid Artery Stents; Renal Artery Stents; Femoral Artery Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; Cook Medical Incorporated; Kyoto Medical Planning Co. Ltd.; Abiomed Inc.; Livanova PLC; BIOTRONIK SE & Co. KG; CryoLife Inc.; Endologix Inc.; Sorin Group; Berlin Heart GmbH; REVA Medical LLC.; Syncardia Systems LLC; Elixir Medical Corporation; Proxy Biomedical Ltd.; Calon Cardio-Technology Ltd.; InspireMD Inc.; Neovasc Inc.; Shree Pacetronix Ltd.; Vascutek Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cardiovascular Implants Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cardiovascular Implants Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cardiovascular Implants Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cardiovascular Implants Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Cardiovascular Implants
    • 4.2.2 Rising Use Of Drug-Eluting And Bioabsorbable Stents
    • 4.2.3 Growing Preference For Transcatheter Heart Valve Procedures
    • 4.2.4 Expansion Of Advanced Cardiac Rhythm Management Devices
    • 4.2.5 Enhanced Focus On Long-Term Implant Durability

5. Cardiovascular Implants Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cardiac Centers
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Heart Clinics
  • 5.5 Interventional Cardiology Centers

6. Cardiovascular Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiovascular Implants Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cardiovascular Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cardiovascular Implants Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cardiovascular Implants Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cardiovascular Implants Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiovascular Implants Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiovascular Implants Market Segmentation

  • 9.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
  • 9.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metals and Alloys, Polymers, Biological Materials
  • 9.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
  • 9.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Cardiac Centers
  • 9.5. Global Cardiovascular Implants Market, Sub-Segmentation Of Coronary Stent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
  • 9.6. Global Cardiovascular Implants Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
  • 9.7. Global Cardiovascular Implants Market, Sub-Segmentation Of Heart Valve, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
  • 9.8. Global Cardiovascular Implants Market, Sub-Segmentation Of Implanted Cardiac Pacemaker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
  • 9.9. Global Cardiovascular Implants Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT) Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
  • 9.10. Global Cardiovascular Implants Market, Sub-Segmentation Of Peripheral Stent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents

10. Cardiovascular Implants Market Regional And Country Analysis

  • 10.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiovascular Implants Market

  • 11.1. Asia-Pacific Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiovascular Implants Market

  • 12.1. China Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiovascular Implants Market

  • 13.1. India Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiovascular Implants Market

  • 14.1. Japan Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiovascular Implants Market

  • 15.1. Australia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiovascular Implants Market

  • 16.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiovascular Implants Market

  • 17.1. South Korea Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiovascular Implants Market

  • 18.1. Taiwan Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiovascular Implants Market

  • 19.1. South East Asia Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiovascular Implants Market

  • 20.1. Western Europe Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiovascular Implants Market

  • 21.1. UK Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiovascular Implants Market

  • 22.1. Germany Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiovascular Implants Market

  • 23.1. France Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiovascular Implants Market

  • 24.1. Italy Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiovascular Implants Market

  • 25.1. Spain Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiovascular Implants Market

  • 26.1. Eastern Europe Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiovascular Implants Market

  • 27.1. Russia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiovascular Implants Market

  • 28.1. North America Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiovascular Implants Market

  • 29.1. USA Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiovascular Implants Market

  • 30.1. Canada Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiovascular Implants Market

  • 31.1. South America Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiovascular Implants Market

  • 32.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiovascular Implants Market

  • 33.1. Middle East Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiovascular Implants Market

  • 34.1. Africa Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiovascular Implants Market Regulatory and Investment Landscape

36. Cardiovascular Implants Market Competitive Landscape And Company Profiles

  • 36.1. Cardiovascular Implants Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cardiovascular Implants Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cardiovascular Implants Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Cardiovascular Implants Market Other Major And Innovative Companies

  • W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd.

38. Global Cardiovascular Implants Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiovascular Implants Market

40. Cardiovascular Implants Market High Potential Countries, Segments and Strategies

  • 40.1 Cardiovascular Implants Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cardiovascular Implants Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cardiovascular Implants Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer